Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: HAWAII BIOTECH, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-20 to 2025-07-22
Current total value of award: $24625516
Description: EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE::EOI TO DEVELOP A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS.